Exclusive Content

Absorption Systems works collaboratively with biotech and pharma companies. Dealing with their future therapeutics, the company’s analytical research services help customers streamline and simplify the approval process. Lu Rahman found out more from CEO Patrick Dentinger. LR: Describe Absorption Systems’ analytical testing expertise in relation to cell and gene therapy PD: As an analytical lab, customers […]

Digital transformations are having wide-ranging and profound impacts within life sciences, creating both opportunities and challenges. One of those challenges is adopting new software systems to drive the transformations. Pharma invests in powerful software technologies with the promise of increased efficiencies, but ultimately, if the interfaces are unintuitive and more difficult than current processes, end […]

This paid-for app note by Eurofins appeared in DDW Volume 21, Issue 4 – Fall 2020. Despite the chaos of 2020, drug discovery has powered on, allbeit with some adaptations. One change has been the increased demand for outsourcing services, particularly from small and mid-sized pharma and biopharma companies eager to cut costs and gain access […]

This paid-for app note by Sciex appeared in DDW Volume 21, Issue 4 – Fall 2020. RUN FAST: This ultra-high sample throughput system for Acoustic Ejection Mass Spectrometry (AEMS) delivers speed, scale and reproducibility with unyielding data quality. The Echo® MS System leverages industry leading quantitative MS technology from SCIEX to deliver a highly sensitive solution […]

The International Society for Cell & Gene Therapy (ISCT) has a vision – to translate cell and gene research into safe and effective therapies to improve patients’ lives worldwide. Queenie Jang, CEO, explains…. Established in 1992, the ISCT  is a global society of over 2300 clinicians, regulators, researchers, technologists and industry partners. Driven by volunteer leaders […]

This paid-for app note by Fortebio appeared in DDW Volume 21, Issue 4 – Fall 2020. Research to end the COVID-19 pandemic has focused on both development of vaccines to prevent infection and therapeutic strategies to treat those already infected. Octet® systems are furthering the understanding of the biomolecular relationship between Coronavirus antibodies, epitope, kinetics and […]

Backed by more than 20 years of research and development expertise, Concarlo Holdings is developing diagnostics and therapeutics that could have huge impact for metastatic breast cancer patients. Lu Rahman finds out more. Stacy Blain, Co-Founder, Concarlo Holdings, wants to change the conversation around breast cancer. This biotechnology start-up whose technologies aim to diagnose and […]

This paid-for app note by Brooks Life Sciences appeared in DDW Volume 21, Issue 4 – Fall 2020. The incredible response from the worldwide scientific community to COVID-19 has led to a focussed surge in activity for many established and new labs. Conversely many labs have had to shut down operations during the pandemic to mitigate […]

The multi-year process of drug discovery and development creates huge silos of data and information. Extracting and combining information can be a significant overhead, resulting in potential for delay and error. Iperion’s Duncan van Rijsbergen provides practical recommendations to help companies create high quality, consistent data that may be shared across systems. Pharmaceutical companies are […]

Lu Rahman looks at the drug repurposing market. How attractive a proposition is it financially?  More than ever the world is watching drug development and is aware of the time it takes to get a drug to market. The 10-15 years that this can involve is costly, so unsurprisingly, drug repurposing has become a credible […]

This paid-for app note by Corning appeared in DDW Volume 21, Issue 4 – Fall 2020. Pancreatic cancer is among the most lethal forms of metastasis and the large majority of these are exocrine in nature. Pancreatic ductal adenocarcinoma (PDAC), an exocrine neoplasm, is the most common and aggressive form of this disease. Lack of effective […]

With COVID-19 taking centre stage in global drug discovery, Lu Rahman looks at opportunities ahead for the sector and where attention might be focussed going forward.  It is clear from the current pandemic that opportunities arise within drug discovery and development when we don’t always expect them. COVID-19 has created an immense global effort centred […]

As the world is rocked by one of the greatest healthcare challenges in living memory, how we treat infectious diseases is becoming one of the key medical questions of our age. Hannah Randles, Health and Life Sciences Champion at Liverpool City Region’s Growth Platform explains how the region’s infectious diseases ecosystem is driving innovation in […]

Lu Rahman speaks to key members of Metabolon on the company’s pioneering work in metabolomics including its innovative collaborations with DNAGenotek and the Institute for Systems Biology. “Metabolon has built an unrivalled global biochemical profiling platform capable of providing metabolite data of unsurpassed quality and coverage,” says Brian Keppler, PhD, Director, Discovery and Translational Sciences at […]

Oksana Sirenko, Senior Scientist, Molecular Devices and Evan Cromwell, President & CEO, Protein Fluidics, explain the benefits of automated organoid assays with microfluidics and 3D imaging. Microfluidic flowchip technology combined with three-dimensional (3D) imaging is a powerful duo poised to change the future of drug discovery and development. The integration of combined technologies into one […]

Dr. Kacey Ronaldson-Bouchard (pictured) explains why adapting cell-based assays from suspension cells to 2D culture, 3D culture, and beyond to ‘patient in a dish’ systems is not an exercise undertaken lightly. However, the effort pays off on many levels.  Our incomplete understanding of human biology and the limited potential for human experimentation underscore the need for […]